New antibody therapy shows promising results for advanced, treatment-refractory pediatric brain cancer
July 21, 2022
[vc_row][vc_column][vc_single_image image="51753" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine...
